- Home
- PHVS vs WT Comparison
PHVS vs WT Comparison
Compare PHVS & WT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- WT
- Stock Information
- Founded
- PHVS 2015
- WT 1985
- Country
- PHVS Switzerland
- WT United States
- Employees
- PHVS N/A
- WT N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- WT Investment Bankers/Brokers/Service
- Sector
- PHVS Health Care
- WT Finance
- Exchange
- PHVS Nasdaq
- WT Nasdaq
- Market Cap
- PHVS 1.6B
- WT 1.9B
- IPO Year
- PHVS 2021
- WT N/A
- Fundamental
- Price
- PHVS $22.46
- WT $12.01
- Analyst Decision
- PHVS Buy
- WT Hold
- Analyst Count
- PHVS 6
- WT 4
- Target Price
- PHVS $36.50
- WT $13.38
- AVG Volume (30 Days)
- PHVS 217.3K
- WT 3.1M
- Earning Date
- PHVS 11-12-2025
- WT 10-31-2025
- Dividend Yield
- PHVS N/A
- WT 1.00%
- EPS Growth
- PHVS N/A
- WT 88.71
- EPS
- PHVS N/A
- WT 0.56
- Revenue
- PHVS N/A
- WT $457,016,000.00
- Revenue This Year
- PHVS N/A
- WT $14.01
- Revenue Next Year
- PHVS N/A
- WT $13.68
- P/E Ratio
- PHVS N/A
- WT $21.35
- Revenue Growth
- PHVS N/A
- WT 12.05
- 52 Week Low
- PHVS $11.51
- WT $7.47
- 52 Week High
- PHVS $26.33
- WT $14.96
- Technical
- Relative Strength Index (RSI)
- PHVS 47.79
- WT 34.87
- Support Level
- PHVS $21.99
- WT $11.54
- Resistance Level
- PHVS $23.64
- WT $12.31
- Average True Range (ATR)
- PHVS 1.28
- WT 0.38
- MACD
- PHVS -0.01
- WT -0.08
- Stochastic Oscillator
- PHVS 52.17
- WT 23.37
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About WT WisdomTree Inc.
WisdomTree Inc is a financial innovator, offering a well-diversified suite of exchange-traded products (ETPs), models and solutions. It offers a broad range of ETFs and exchange-traded products (ETPs). The firm also engages in developing next-generation digital products and structures, including digital funds and tokenized assets, as well as its blockchain-native digital wallet, WisdomTree Prime. The Company conducts business under a single operating segment as an ETP sponsor and asset manager.